Jocelyn Solis-Moreira

Jocelyn Solis-Moreira

Feature Writer

B.Sc. Integrative Neuroscience, M.Sc. Psychology

Jocelyn Solis-Moreira graduated with a Bachelor's in Integrative Neuroscience, where she then pursued graduate research looking at the long-term effects of adolescent binge drinking on the brain's neurochemistry in adulthood. She is adept at translating and summarizing complex study findings in all medical fields with a particular interest in neurodegenerative diseases, cancer research, infectious diseases, and public health. As a freelance writer, her work spans from news articles and feature articles to evergreen explainers across many publications. Her overall goal is to make science accessible for all.

Articles from Jocelyn

Evidence of monoclonal antibodies effectively neutralizing SARS-CoV-2 variants

Evidence of monoclonal antibodies effectively neutralizing SARS-CoV-2 variants

RNA-binding cylinders inhibit SARS-CoV-2 replication in vitro

RNA-binding cylinders inhibit SARS-CoV-2 replication in vitro

Research surveys hygiene practices in food supply chains during COVID-19 pandemic

Research surveys hygiene practices in food supply chains during COVID-19 pandemic

Higher B.1.1.7 transmission in households than other SARS-CoV-2 variants

Higher B.1.1.7 transmission in households than other SARS-CoV-2 variants

Study finds CD8+ T cell responses detect all major SARS-CoV-2 variants

Study finds CD8+ T cell responses detect all major SARS-CoV-2 variants

Study estimates impact of amino acid changes on SARS-CoV-2 infection

Study estimates impact of amino acid changes on SARS-CoV-2 infection

Study reports on two cats that caught COVID-19

Study reports on two cats that caught COVID-19

Study of twins reveals differences in adaptive immunity towards SARS-CoV-2

Study of twins reveals differences in adaptive immunity towards SARS-CoV-2

New coronavirus variant with E484K mutation detected in Arizona

New coronavirus variant with E484K mutation detected in Arizona

Vaccine-induced 2C08 antibody protects against SARS-CoV-2 variants

Vaccine-induced 2C08 antibody protects against SARS-CoV-2 variants